Ideal Option Reports 97 Percent Opioid Abstinence Rate in Alaska Clinics

Ideal Option has released its 2025 patient outcomes report, detailing the effectiveness of its outpatient medication-assisted treatment (MAT) program in Alaska. The data shows that 97 percent of patients engaged in long-term treatment remained abstinent from opioids, a significant metric given the state’s ongoing public health struggle with overdose mortality.

The report addresses the growing complexity of substance use in the region, characterized by a shift toward polysubstance use. By utilizing an outpatient model, Ideal Option aims to increase accessibility to care in an environment where residential capacity is often constrained.

These findings arrive as Alaskan health officials continue to address high rates of addiction. The report serves to quantify the impact of outpatient clinical interventions in stabilizing patients and mitigating the risks associated with long-term opioid use.